Gujarat Themis Biosyn will acquire 100% stake in Japan-based MicroBiopharm Japan Co. for about ₹1,300 crore through its ...
South Korea's Hanwha Aerospace said Friday it teamed up with Estonia's Milrem Robotics for Romania's unmanned ground vehicle, ...
Meeting between Japanese PM and co-founder of Palantir, has fueled debate on AI military intelligence systems into its ...
The deadline to start winning in the 2026 VGH+ Hometown Heroes Lottery is almost here. The cutoff to be entered in the Welcome Bonus draw is this Friday night.... The University of British Columbia ...
Get all latest & breaking news on Jubilant Pharmova. Watch videos, top stories and articles on Jubilant Pharmova at ...
Expense reports show former New Britain Mayor Erin Stewart bought clothes, shoes and cosmetics on the city’s credit card, ...
1st May 2026: We added a new Tears of Themis code. Tears of Themis is a popular free-to-play visual novel from Genshin Impact makers HoYoverse. Blending dating sim and detective games, it mashes up ...
Mumbai: Gujarat Themis Biosyn is making a decisive global push, betting on a high-value pharmaceutical portfolio to scale beyond its traditional base. The company has signed an agreement to acquire ...
2-Year U.S. Treasury Note Continuous Contract $103.152-0.035-0.03% 5-Year U.S. Treasury Note Continuous Contract $106.859 0.023 0.02% 10-Year U.S. Treasury Note Continuous Contract $109.406 0.172 0.16 ...
Themis Medicare Limited is a research-based pharmaceutical company, which is engaged in the manufacturing of pharmaceutical products, especially in formulation and active pharmaceutical ingredients ...
The company will continue to derive strength from the existence of experienced promoters and positive outlook for the GLP1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results